Compositions and methods for treatment of cystic fibrosis
AssigneesUniversity of Iowa Research Foundation, Spirovant Sciences, Inc.
InventorsJohn F. Engelhardt, Ziying Yan, Yinghua Tang, Eric Yuen, Shen Lin
Life of this patent
Estimating the term…
Loading patent…
AssigneesUniversity of Iowa Research Foundation, Spirovant Sciences, Inc.
InventorsJohn F. Engelhardt, Ziying Yan, Yinghua Tang, Eric Yuen, Shen Lin
Estimating the term…
Provided herein are polynucleotides, rAAV vectors, pharmaceutical compositions, and methods of making and using the same, e.g., for treatment of cystic fibrosis (CF). For example, the disclosure provides a recombinant adeno-associated vims (rAAV) that includes, in one embodiment, an AV.TL65 capsid protein and a polynucleotide that includes an F5 enhancer and a tg83 promoter operably linked to a CFTRΔR minigene, pharmaceutical compositions thereof, and methods of use thereof, e.g., for treatment of CF.
A recombinant adeno-associated virus (rAAV) comprising (i) an AV.TL65 capsid protein or a variant thereof;
(canceled)
14-19. (canceled)
A recombinant adeno-associated virus (rAAV) comprising the sequence of SEQ ID NO:7 or a variant thereof with at least 80% nucleic acid sequence identity to SEQ ID NO:7.
Dependencies are inferred from the claim text.